Eligo Bioscience
Developer of in vivo gene editing technology for microbiome modulation. The company offers a platform to edit the microbiome's gene repertoire. This platform aims to address diseases triggered or aggravated by specific bacterial genes. The technology targets the interactions between the microbiome and the host's immune system. Founded in 2014, headquartered in Paris, France. The company has raised $52.3M in funding…
Funding snapshot
About
Developer of in vivo gene editing technology for microbiome modulation. The company offers a platform to edit the microbiome's gene repertoire. This platform aims to address diseases triggered or aggravated by specific bacterial genes. The technology targets the interactions between the microbiome and the host's immune system. Founded in 2014, headquartered in Paris, France. The company has raised $52.3M in funding at the series b stage. The team comprises 47 (Jun 30, 2026) employees. Eligo Bioscience operates in the Genomics sector. The company focuses on Gene Editing. Notable investors include Sanofi Ventures, Bpifrance, Khosla Ventures, Seventure Partners, EIC Fund, Europa, among others. The company has a team of 47 employees.
Business model
Genomics > Enabling Technologies > Technology Platforms > Gene Editing
Team background
College Wise > Massachusetts Institute of Technology
Institutional investors
Backed by funds in our directory
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.